Scientific life-saving technology for both providers and patients.
The Increasing Risk: DVT
An increasing condition that affects as many as 900,000 people each year in the United States, 10 to 30% of people will die within one month of diagnosis of DVT/PE. Sudden death is the first symptom in about 25% of people who have a PE.
Among people who have had a DVT, 50% will have long-term complications such as swelling, pain, discoloration, and scaling in the affected limb. One-third of people with DVT/PE will have a recurrence within 10 years. Approximately 5 to 8% of the U.S. population has a genetic risk factor, in which a defect can be identified that increases the risk for DVT.
PREVENT HOSPITAL READMISSIONS
Compact, portable, and easy for patients to use at home
When a patient must be readmitted to the hospital because of post-surgical DVT, the result can be devastating for everyone involved. The fact is, nearly 50 percent of all DVT cases happen after a patient is discharged. Our products reduce this risk to patients- and their providers- by decreasing the likelihood of life-threatening, post-surgical DVT during the very vulnerable first week after discharge. Designed to promote the continuum of care from the hospital to home after surgery, our products are compact, portable and easy for patients to use in the comfort of their own homes.
The Importance of Home Prevention
Many factors determine your risk for DVT but studies show you're at highest risk five to ten days after surgery. With today's shorter hospital stay, that's most likely when you're recovering at home, away from the watchful eye of your health care providers. Therefore, it's vital that life-saving DVT prevention doesn't end at the time of discharge after surgery but continues at home throughout your most vulnerable days.
Physicians can prescribe DVT prevention for use at home. See our Product page for more information.
NEVER EVENTS: PREVENTABLE ERRORS
DVT is the leading cause of preventable hospital deaths
They not only harm patients, but hospitals as well, resulting in costly fines or loss of reimbursement. The Centers for Medicare & Medicaid Services have deemed DVT a never event. Still, DVT is the leading cause of preventable hospital deaths. Research shows 1 in 100 patients admitted to a hospital dies because of pulmonary embolism (PE), which is a result of DVT. Hospitals and surgical centers can affordably prevent life-threatening DVT never events with take home DVT products.
Want to know more about DVT prevention for facilities? Contact us for more info today.
COST TO PREVENT VS. TREAT
On the cutting edge of the DVT-prevention industry
As with most other diseases, preventing DVT is substantially less expensive than treating its consequences. The cost to diagnose and treat DVT and its effects in the Unites States is estimated to be as much as $23.8 billion per year. According to the Centers for Medicare & Medicaid Services (CMS), DVT treatment costs an average of $50,937 per patient.
Ready to get started? Reach out with any questions, comments or request for more information.